Celebrating Young Talent and Advancements in Cancer Treatment

This chapter highlights the approval of Belantamab mafodotin as a groundbreaking cancer treatment with high remission rates. It also covers King Charles III's award ceremony that recognizes young talent and emphasizes sustainability and the arts, celebrating his foundation's 35th anniversary.